Adenomyosis: A Contemporary Clinical Review with Ayurvedic Perspectives on Etiopathogenesis and Management

In: International Journal For Multidisciplinary Research · 2026 · vol. 8(5) · doi:10.36948/ijfmr.2026.v08i05.88159 · W7214598089
Review OA: hybrid CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-26 ⓘ

This review integrates Ayurvedic perspectives on adenomyosis etiopathogenesis and management with modern clinical data to provide a comprehensive framework for symptom control, disease management, and fertility preservation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-26 · read from full text ⓘ

This review article examines the contemporary clinical understanding of adenomyosis, detailing its epidemiology, multifactorial pathogenesis involving endometrial invagination and inflammation, and diagnostic modalities such as MRI and histopathology. The authors integrate an Ayurvedic framework to interpret the condition as a Yonivyapad Upadrava, correlating symptoms like menorrhagia and pelvic pain with classical concepts of Asrigdara, Gulma, and Granthi. Management strategies discussed include both modern medical interventions like LNG-IUS and conservative surgery, alongside Ayurvedic principles aimed at symptom control and fertility preservation through individualized Shamana and Shodhana therapies. This paper is centrally about adenomyosis — specifically exploring its etiology, diagnosis, and integrated management approaches from both allopathic and traditional Indian medicine perspectives.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis - once regarded as a disease of multiparous women in the fifth decade, is increasingly recognized in younger women of reproductive age, with a prevalence of 20-35% in the general population and 20-65% among women undergoing hysterectomy, causing significant physical, psychological, reproductive and socioeconomic burden through menorrhagia, dysmenorrhoea, chronic pelvic pain and subfertility. This review summarizes its definition, etiopathogenesis, risk factors, classification, clinical features, diagnosis and management while integrating an Ayurvedic perspective, as adenomyosis has no direct one-to-one equivalent in classical texts. Modern theories implicate endometrial invagination, tissue injury and repair at the endo-myometrial junctional zone, altered steroidogenesis and chronic inflammatory-angiogenic changes; diagnosis relies mainly on transvaginal ultrasonography and MRI, with histopathology as the gold standard. Within Ayurveda, adenomyosis may be interpreted as a Yonivyapad-Upadrava with clinical and pathological features showing conceptual parallels with Asrigdara, Gulma and Granthi, rather than being equated directly with any single classical disease. A predominantly Vata-Pitta pathology with secondary chronic Kapha-Mamsa involvement can be considered, affecting Rasa, Rakta, Artava and Mamsa Dhatu and involving Artavavaha, Rasavaha and Raktavaha Srotas. The proposed Samprapti involves Dosha-Dushya Sammurchana, Srotosanga and subsequent Vimarga Gamana at the Yoni-Garbhashaya, accounting for abnormal uterine bleeding, dysmenorrhoea, pelvic pain and uterine enlargement. Management follows the principle of Samprapti Vighatana through individualized Shamana, Shodhana and Sthanika Chikitsa, supported by classical formulations with potential anti-inflammatory and antioxidant actions. An integrated modern and Ayurvedic understanding may provide a comprehensive framework for symptom control, disease management, fertility preservation and improved quality of life alongside modern gynaecological care.
Full text 23,799 characters · extracted from oa-pdf · 6 sections · click to expand

Abstract

Adenomyosis - once regarded as a disease of multiparous women in the fifth decade, is increasingly recognized in younger women of reproductive age, with a prevalence of 20-35% in the general population and 20 -65% among women undergoing hysterectomy, causing significant physical, psychological, reproductive and socioeconomic burden through menorrhagia, dysmenorrhoea, chronic pelvic pain and subfertility. This review summarizes its d efinition, etiopathogenesis, risk factors, classification, clinical features, diagnosis and management while integrating an Ayurvedic perspective, as adenomyosis has no direct one-to-one equivalent in classical texts. Modern theories implicate endometrial invagination, tissue injury and repair at the endo -myometrial junctional zone, altered steroidogenesis and chronic inflammatory-angiogenic changes; diagnosis relies mainly on transvaginal ultrasonography and MRI, with histopathology as the gold standard. Within Ayurveda, adenomyosis may be interpreted as a Yonivyapad- Upadrava with clinical and pathological features showing conceptual parallels with Asrigdara, Gulma and Granthi, rather than being equated directly with any single classical disease. A predomin antly Vata-Pitta pathology with secondary chronic Kapha-Mamsa involvement can be considered, affecting Rasa, Rakta, Artava and Mamsa Dhatu and involving Artavavaha, Rasavaha and Raktavaha Srotas. The proposed Samprapti involves Dosha -Dushya Sammurchana, Sr otosanga and subsequent Vimarga Gamana at the Yoni-Garbhashaya, accounting for abnormal uterine bleeding, dysmenorrhoea, pelvic pain and uterine enlargement. Management follows the principle of Samprapti Vighatana through individualized Shamana, Shodhana and Sthanika Chikitsa, supported by classical formulations with potential anti -inflammatory and antioxidant actions. An integrated modern and Ayurvedic understanding may provide a comprehensive framework for symptom control, disease management, fertility preservation and improved quality of life alongside modern gynaecological care.

Keywords

Adenomyosis; Yonivyapad Upadrava; Asrigdara; Gulma; Granthi; Samprapti; Apana Vata Anulomana; Uttarabasti.

Introduction

Adenomyosis was once believed to be a disease co nfined largely to multiparous women approaching the perimenopausal years. It is now, however, increasingly diagnosed in younger women of reproductive age, International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 2 making it a significant public health concern rather than a condition of incidental late -life discovery. Its prevalence is reported to range between 20% and 35% in the general female population, rising to 20-65% among women undergoing hysterectomy for benign indications. Through the cardinal manifestations of heavy and prolonged menstrual bleeding, progre ssive dysmenorrhoea, chronic pelvic pain, and impaired fertility, adenomyosis imposes a substantial physical, psychological, reproductive and socioeconomic burden on affected women. This changing epidemiological profile highlights the need for greater clinical awareness, earlier diagnosis and fertility-preserving treatment strategies that extend beyond the traditionally definitive but fertility - ending option of hysterectomy. In this context, exploring adenomyosis through the lens of Ayurveda offers a br oader understanding of its pathogenesis and provides holistic therapeutic interventions aimed at symptom control, disease modification, and improvement in overall quality of life. Definition and etiopathogenesis of Adenomyosis Adenomyosis is defined as the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus with ectopic, non -neoplastic endometrial glands and stroma surrounded by hypertrophic and hyperplastic myometrium.¹ Its pathogenesis is multifactorial, involving basalis endometrial invagination through a disrupted endo -myometrial junctional zone (invagination theory), repetitive tissue injury and repair (TIAR), displaced Müllerian remnants, and metaplastic transformation of myometrial stem/progenitor cells.²˒³ Ris k factors include multiparity, early first delivery, early menarche, short menstrual cycles, and uterine trauma from caesarean section, D&C, MTP, hysteroscopy, manual placental removal and myomectomy.¹˒³˒⁴ Genetic/epigenetic factors, local hyperestrogenism with aromatase overexpression, progesterone resistance, inflammation, angiogenesis and oxidative stress contribute to disease progression; obesity and psychological stress may also contribute.²˒⁵ According to Molitor’s criteria, adenomyosis is graded by depth of myometrial invasion: Grade I-inner one-third, Grade II-middle one-third, and Grade III-outer one-third.¹³ Clinically, it may be diffuse or focal (adenomyoma) and superficial or deep.⁵˒¹³ Clinical features, diagnosis and management The main manife stations are heavy/prolonged menstrual bleeding, progressive dysmenorrhoea, chronic pelvic pain, intermenstrual spotting and subfertility.⁵˒¹³ The uterus is usually uniformly enlarged, soft, boggy and tender (Halban’s sign), often corresponding to about 12 –14 weeks’ gestation.⁵ TVUS is the first-line investigation and may show a globular uterus, asymmetrical myometrial thickening, heterogeneous echotexture, myometrial cysts, fan-shaped shadowing, echogenic striations and an irregular junctional zone; MRI is the best non -invasive imaging modality, typically showing junctional -zone thickening ≥12 mm, myometrial cysts and hemorrhagic foci.¹³ Histopathology remains the definitive gold standard, with diffuse myometrial involvement and small blood -filled cystic sp aces producing the characteristic “burnt matchstick” appearance.⁵ Management is individualized according to symptoms, age and fertility wishes. Medical treatment includes NSAIDs, combined oral contraceptives, GnRH agonists and LNG -IUS for symptom control.⁵ ˒¹³ Conservative surgical options include adenomyomectomy, myometrial reduction and endometrial ablation/resection, while hysterectomy is definitive treatment for women who have completed childbearing or when conservative treatment fails.⁵˒¹³ AN AYURVEDIC UNDERSTANDING OF ADENOMYOSIS AND ITS MANAGEMENT Adenomyosis has no direct nosological correlation described in the Ayurvedic classics. It is best understood as a chronic pathological consequence involving multiple Dosha and Dushya, developing after International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 3 prolonged Dosha-Dushya Sammurchana and Garbhashaya Vikriti. Based on its Samprapti and Lakshanas, the condition closely resembles the Upadravas of Yonivyapad - particularly Asrigdara, Gulma, and Vandhyatva. Considering adenomyosis as a Yonivyapad Upadrava, rather than restricting it to a single classical disease entity, provides a more comprehensive Ayurvedic correlation. This framework explains the simultaneous involvement of Dosha, Dushya, Srotas, and Ashaya, offering a rational Ayurvedic approach to both understanding and managing adenomyosis.7,12 Na shukram dharayatyebhirdoshair yonir upadruta, tasmad garbham na grihnati stri gacchaty amayan bahun. Gulma-arshah pradaradims cha vata-adyaish cha atipidanam. (Caraka Samhita, Chikitsa Sthana 30/38-39) When the Yoni is afflicted by these vitiated Doshas, it cannot retain the Shukra; consequently, the woman fails to conceive and suffers from numerous disorders - Gulma, Arsha, Pradara, and other conditions arising from the excessive aggravation of Vata and the other Doshas.7 Correlation with Asrigdara Asrigdara denotes the condition in which menstrual blood (Rajah) is discharged in a Prolonged and profuse manner (Pradiryate); the term is thus applied when bleeding occurs excessively (Atiprasanga) and even outside the expected menstrual period (Anrtavapi), distinct from bleeding due to other causes, and is invariably accompanied by generalised body ache (Angamarda) and pain (Vedana). 6 Vata vitiated at the Kati (low back), Vankshana (groin), Hrit (upper abdomen), Pa rshva (flanks), Prishtha (back), and Sroni (pelvis) causes Asrigdara to be discharged repeatedly (Muhurmuhuh), accompanied by pain.7 Classical Term Clinical Correlate Atiprasanga pravritta anrtavapi Menorrhagia and intermenstrual bleeding Kati vedana Low back pain Vankshana vedana Groin pain Sroni vedana Chronic pelvic pain Tivra vedana Progressive severe pain / severe dysmenorrhoea Muhurmuhur raktasrava Premenstrual spotting, prolonged bleeding, abnormal uterine bleeding Daha, Raga Chronic inflammatory process, vascular congestion Bhrama Anaemia-related giddiness in women with heavy bleeding Correlation with Gulma Gulma is described as that which lodges firmly (station itself) in the Hrid, Basti, Parshva, or Nabhi, giving rise to pain (Shu la) and multiple nodular swellings (Granthi), and which persists as a rounded, compact (Pindita) mass - hence the designation "Gulma".8 Classical Term Clinical Correlate Kathina pinda Firm, bulky uterus Shula Chronic pelvic pain Muhur adhmana Pelvic heaviness and pressure Glani Generalised tiredness International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 4 Chalatva of Vata Cyclic manifestation of symptoms Kuksim abhivartayati Enlarged uterus Correlation with Granthi Granthi arises when vitiated Vata and other Doshas afflict Mamsa and Rakta, and together with Kapha- associated Meda, produce a rounded, elevated, and firmly knotted swelling (Shopha). 9 A Granthi also forms when Rakta is vitiated by the Doshas, involving the Sira and Mamsa, with features predominantly of Pitta.10,11 Classical Term Clinical Correlate Rakta Dushti - Pitta lakshana Chronic inflammation and vascular congestion Toda Chronic pelvic pain Mamsa Samsrishta Bulky uterus due to myometrial hypertrophy Granthi-sadrisha Mamsa Vriddhi Localised / focal adenomyosis SAMPRAPTI Samprapti Ghataka Ghataka Description Dosha Vata pradhana Tridosha Dushya Rasa, Rakta, Artava, Mamsa Srotas Rasa-Rakta-Artava-Mamsavaha Srotodushti prakara Sanga progressing to Vimarga Gamana Adhishthana Yoni - Garbhashaya Sandhi Agni Jatharagni and Dhatvagni Mandya Vyadhi Marga Abhyantara Sadhyasadhyata Kricchrasadhya Ayurvedic Samprapti and Modern Clinical Correlation Repeated Mithyachara acting as Nidana - such as prior curettage, caesarean section, or uterine surgery - corresponds to disruption and microinjury at the junctional zone (endo -myometrial interface). The resulting Vata -Pitta-Rakta Sanga at the Garbhashaya Sandhi corresponds to invagination of basalis endometrium into the myometrium, as described in the invagination theory. C hronic Sanga obstructing the normal Gati of Vata parallels the smooth -muscle hyperplasia and hypertrophy that develops around ectopic glands and stroma, while secondary Kapha-Mamsa Dushti and consequent Mamsonnati represent this later, chronic structural r emodelling rather than an initiating event. Dushta Artava and Vimarga Gamana of Rakta correspond to local hyperestrogenism, which sustains ectopic growth and progressive myometrial remodelling. The clinical picture of a bulky, tender uterus with menorrhagia, dysmenorrhoea, and chronic pelvic pain is understood as the resultant Upadrava - manifesting as Gulma, Pradara, and Shula.7,12 Lakshana (Clinical Features) - Ayurvedic and Modern Correlation Ayurvedic Lakshana Modern Clinical Correlate Gulma-like Garbhashaya Vriddhi Diffusely bulky, globular uterus International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 5 Asrigdhara Menorrhagia / prolonged and heavy menstrual bleeding Yonishula, Kati-Vankshana Shula Dysmenorrhoea, chronic pelvic pain, low -back and groin pain Artava Dushti Irregular cycles, intermenstrual spotting Vandhyatva Subfertility associated with junctional -zone dysfunction Daurbalya, Panduta (from Rakta Kshaya) Anaemia secondary to chronic heavy blood loss AYURVEDIC MANAGEMENT Guiding Principle Sarvam vyapanna-yonim tu karmabhir vamanadibhih, mridubhih panchabhir narim snigdha-svinnam upacharet. Sarvatah suvishuddhayah shesham karma vidhiyate, yac cha vata-vikaranam karmoktam tac cha karayet. Nahi vatad rite yonir narinam sampradushyati. (Caraka Samhita, Chikitsa Sthana 30) In all forms of Yonivyapad, the woman is first prepared with Snehana and Swedana and then treated gently (Mridu) with the five Panchakarma procedures. Once she is thoroughly purified (Suvishuddha), the remaining specific treatment is administered, and the measu res prescribed for Vata disorders should also be carried out - for no Yonivyapad in women arises without the involvement of Vata. This principle establishes Vata Anulomana as the therapeutic cornerstone across the Shamana, Shodhana, and Sthanika Chikitsa described below.7 Samana Chikitsa In milder or actively bleeding presentations where immediate Shodhana is not appropriate, Samana Chikitsa is employed to pacify the vitiated Doshas through internal medications selected according to the predominant Dosha an d symptom profile, thereby controlling pain and bleeding before, or in place of, Shodhana Karma. Shodhana Chikitsa Snehana Purpose: Vata Shamana and Dosha Utkleshana, preparing the vitiated Doshas for elimination. Formulations: Salmali Ghrita, Shatavari Ghrita, Mahatiktaka Ghrita, Shatapushpa Taila. Swedana Purpose: Srotovishodhana, Sanga Bhedana, Shoola Prashamana, and Dosha Vilayana. Virechana Indicated in the presence of Rakta-Pitta Dushti Lakshanas. Formulations: Trivrit Avaleha (mild Virechana), Avipattikara Churna (for Pitta), Gandharvahastadi Eranda Taila (Vata-Pitta), and Nimbamritadi Eranda Taila (for inflammation). Basti Purpose: Apana Vata Anulomana and Srotoshodhana. Formulations: Chandanadi Niruha Basti, Rasnadi Niruha Basti, Lodradi Asthapana Basti, Mustadi Yapana Basti, Madhukadi Anuvasana Basti, and Dhanwantaram Taila Anuvasana Basti. International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 6 Uttarabasti Administered after active inflammation and heavy bleeding are controlled. Purpose: Artavavaha Srotoshodhana, Apana Vata Anulomana, and Garbhashaya Balya. Tatah samshuddha-koshasya nirudhad uttaram yatah, diyate cha uttaram bastir uttaram sa nirucyate. (Sharngadhara Samhita) Ritukale hi narinam garbhashayah sukham vivrito bhavati, tasmat tasmin kale sneham ativa grihnati. (Sushruta Samhita, Chikitsa Sthana) Symptom-management formulations: Sahacharadi Taila, Dhanwantara Taila, Mahanarayana Taila, Bala Taila, Shatavari Ghrita, Guduchi Swarasa Siddha Taila, and Tiktaka Ghrita. Fertility-oriented formulations: Phala Ghrita, Shatapushpa Taila, Jeevaniya Ghrita, and Dhanwantara Taila. Rationale of Key Formulations (Rasapanchaka and Phytochemical Correlates) The following formulation-level reasoning integrates classical Rasapanchaka with reported phytochemical and pharmacological correlates: Formulation Ayurvedic Rationale / Rasapanchaka Correlate / Reference Brihat Shatavari Ghrita Vrishya; corrects Yoni -Asrik-Shukra Dosha; pacifies Vata-Pitta Shatavari steroidal saponins (shatavarin IV) show phytoestrogenic and uterine - tonic activity. Ca. Chi. 30/64-68 Pushyanuga Churna Classical formulation for Pradara / Asrigdara; Kapha -Pitta pacifying, Rakta-stambhaka Lodhra and Ashoka constituents reported to reduce endometrial vascularity and bleeding. Ca. Chi. 30 (Asrigdara section) Guduchi-Bala-Rasna Taila (Uttarabasti) Vata-shamaka and Vrana -ropaka at Yoni-Garbhashaya Sandhi; supports local tissue repair Guduchi shows anti - inflammatory and immunomodulatory action. Ca. Chi. 30/59-60 Phala Ghrita Madhura-Tikta-Kashaya Rasa, Guru- Snigdha Guna, Sheeta Veerya, Madhura Vipaka; Garbhashaya Balya, Artava Janana, Rasayana, Vata -Pitta Shamana For Garbhashaya Daurbalya and infertility. A.H. Uttara Tantra (Vandhyatva Chikitsa); Bhaishajya Ratnavali Tikta Ghrita Tikta Rasa, Guru -Snigdha Guna, Sheeta Veerya, Madhura Vipaka; Pitta Shamana, Rakta Prasadana, Deepana, Srotoshodhana, Rasayana Reduces Pitta-Rakta Dushti and Shotha; ideal Snehapana before Virechana. Ca. Chi. (Kushtha); A.H. Chi. Trivrit Lehya Madhura-Tikta Rasa, Laghu -Snigdha Guna, Ushna Veerya, Madhura Vipaka; Mridu Virechana, Pitta Nirharana, Anulomana For Pitta -Rakta Prakopa with heavy bleeding, prior to Basti. Ca. Kalpa Sthana International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 7 Avipattikara Churna Madhura-Tikta-Katu Rasa, Laghu - Ruksha Guna, Sheeta Veerya, Madhura Vipaka; Pi tta Shamana, Deepana, Pachana, Mridu Virechana For Mandagni with mild inflammatory stage. Bhaishajya Ratnavali (Amlapitta Adhikara) Gandharvahastadi Taila Katu-Tikta Rasa, Snigdha -Tikshna Guna, Ushna Veerya, Katu Vipaka; Vatahara, Anulomana, Mridu Virechana For Vata -Pitta predominance with constipation. Sahasrayoga Dhanvantaram Taila Madhura-Tikta Rasa, Guru -Snigdha Guna, Ushna Veerya, Madhura Vipaka; Balya, Brimhana, Vatahara For chronic Vata disorders and Garbhashaya Daurbalya. A.H. Uttara Tantra; Sahasrayoga Dashamoola Taila Kashaya-Tikta-Katu Rasa, Snigdha Guna, Ushna Veerya, Katu Vipaka; Vatahara, Shoolahara, Shothahara For chronic pelvic pain with Vata predominance. Sahasrayoga Balashwagandhadi Taila Madhura Rasa, Guru -Snigdha Guna, Ushna Veer ya, Madhura Vipaka; Balya, Brimhana, Mamsa Poshana For Mamsa Dhatu Kshaya and weak uterus. Sahasrayoga Sahacharadi Taila Tikta-Katu Rasa, Snigdha Guna, Ushna Veerya, Katu Vipaka; Vedanasthapana, Vatahara For severe pelvic pain with Vata predominance. Sahasrayoga Shatapushpa Taila (Uttarabasti) Katu-Tikta Rasa, Laghu -Snigdha Guna, Ushna Veerya, Katu Vipaka; Artava Janana, Vatahara, Apana Vata Anulomana For Artava Dushti and infertility. A.H. Uttara Tantra; Sahasrayoga Bala Taila (Uttarabasti) Madhura Rasa , Guru -Snigdha Guna, Sheeta Veerya, Madhura Vipaka; Balya, Brimhana, Vatahara For Dhatu Kshaya and weak Garbhashaya. Sahasrayoga Mahanarayana Taila (Uttarabasti) Madhura-Tikta Rasa, Guru -Snigdha Guna, Ushna Veerya, Madhura Vipaka; Balya, Brimhana, Vatahara, Shoolahara For chronic Vata disorders, persistent pelvic pain, and uterine tissue weakness. Sahasrayoga

Discussion

Adenomyosis can be approached through the principle of Samprapti Vighatana - targeting the involved Dosha, Dushya, Srotas, and Agni rather than treating symptoms in isolation. Its progression can further be interpreted through the sequential evolution of Roga Avastha, tracing the course from initial Dosha vitiation to established structural pathology at the Yoni-Garbhashaya Sandhi. Apana Vata Anulomana forms the therapeutic basis for addressing pain, dysmenorrhoea, and altered uterine function, consistent with the classical dictum that no Yonivyapad arises without the involvement of Vata. Pitta -Rakta Prashamana and Shothahara approa ches complement this by controlling excessive bleeding and the underlying inflammatory changes. Kapha -Mamsa Dushti, manifesting as Mamsonnati and localised Granthi -like induration, is best understood as a secondary, chronic development International Journal for Multidisciplinary Research (IJFMR) E-ISSN: 2582-2160 ● Website: www.ijfmr.com ● Email: [email protected] IJFMR260588159 Volume 8, Issue 5, September-October 2026 8 superimposed on this Vata-Pitta pradhana process rather than as an initiating factor - a distinction that has direct bearing on sequencing of Shodhana and Shamana therapies. A holistic approach incorporating Pathya -Apathya, lifestyle modification, Rasayana, and Garbhashaya Balya measures further supports symptom control and quality of life, positioning Ayurvedic management as a complementary framework alongside modern medical and surgical care rather than a replacement for it.

Conclusion

The rising prevalence of adenomyosis a nd its increasing recognition as a major women's health problem warrant greater clinical attention. The disease profoundly affects quality of life through heavy menstrual bleeding, severe dysmenorrhoea, chronic pelvic pain, infertility, anaemia, and psycho logical distress. Early recognition and timely management are essential to reduce disease burden and preserve reproductive potential. Although adenomyosis has no direct description in Ayurveda, it can be rationally understood through Ayurvedic principles a s a Yonivyapad Upadrava. Ayurvedic management emphasises individualised Shamana, Shodhana, and Sthanika Chikitsa, aiming to address the underlying pathology while improving quality of life - offering a valuable integrative dimension to the contemporary car e of women with adenomyosis.

References

1. Bird CC, McElin TW, Manalo -Estrella P. The elusive adenomyosis of the uterus - revisited. Am J Obstet Gynecol. 1972;112(5):583-93. 2. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592-601. 3. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update. 2014;20(3):386-402. 4. Brosens I, Pijnenborg R, Benagiano G. Defective myometrial spiral artery remodelling as a cause of major obstetrical syndromes in endometriosis and adenomyosis. Placenta. 2013;34(2):100-5. 5. Berek JS, Berek DL, editors. Berek & Novak's Gynecology. 16th ed. Philadelphia: Wolters Kluwer; 2020. 6. Sushruta. Sushruta Samhita, Sharira Sthana, Aturopakramaniya Adhyaya 2/18 -19 (definition of Asrigdara). 7. Agnivesha. Charaka Samhita, revised by Charaka and Dridhabala, Chikitsa Sthana, Yonivyapad Chikitsa Adhyaya 30/5-70. 8. Charaka. Charaka Samhita, Nidana Sthana, Gulma Nidana Adhyaya 3. 9. Sushruta. Sushruta Samhita, Nidana Sthana, Vata-vyadhi Nidana Adhyaya 11/3. 10. Vagbhata. Astanga Sangraha, Uttara Sthana, Adhyaya 34/7. 11. Vagbhata. Astanga Hridaya, Uttara Sthana, Guhya Roga Vijnaniya Adhyaya 33. 12. Tewari PV. A Textbook of Prasuti Tantra (Obstetrics). Varanasi: Chaukhambha Orient; 2004. 13. Howkins J, Bourne G, Shaw RW. Shaw's Textbook of Gynaecology. 18th ed. New Delhi: Elsevier ; 2023.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (4)

Source provenance

openalex
last seen: 2026-11-20T06:09:37.170340+00:00
License: CC0 · commercial use OK